This research delineates metabolic differences between glioma grades and identifies critical genes in glioma metabolism, offering new insights into glioma progression and treatment strategies, with a focus on PDE8B as a pivotal metabolic enzyme. This evidence concerns the gene PDE8B and central nervous system cancer.